Getting into the details of dosing and devices that administer the medication is important: FDA-approved doses should be increased only under the ongoing supervision of the prescribing medical professional
GLP-1s do, however, seem to have a lower barrier of entry, as 12% of adults have reported using GLP-1s, as compared to the 1% of eligible adults that have received bariatric surgery
While the FDA did not conclude that the drugs caused those events, the warning letter reflects the level of scrutiny these medications now face from federal regulators
[34] If you experience severe or persistent side effects , contact your GP promptly or seek urgent medical attention via NHS 111, 999, or A&E if symptoms are severe
Foundayo (orforglipron) Approved uses : Adults with obesity or adults with overweight and at least one weight-related condition